aluates Reports

$ 0.0

Automative

Global DNA Vaccines Market Research Report 2026

Published Date: 2026-03-06

Report Code: QYRE-Auto-4I12362

Global DNA Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

BUY CHAPTERS

Global DNA Vaccines Market Research Report 2026

Code: QYRE-Auto-4I12362

Report

2026-03-06

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

GSK

Elanco

Boehringer Ingelheim

Indian Immunologicals

Plumbline Life Sciences

Sanofi

Zoties

DNA Vaccines Market Size

The global DNA Vaccines market was valued at US$ 5751 million in 2025 and is anticipated to reach US$ 9597 million by 2032, at a CAGR of 7.7% from 2026 to 2032.

DNA Vaccines Market

DNA vaccines are vaccines that use recombinant DNA technology, introducing plasmids or other DNA vectors encoding specific antigens of a pathogen into the host organism, where host cells transcribe and translate the antigen, thus eliciting a specific immune response. Compared to traditional inactivated or attenuated vaccines, DNA vaccines offer flexibility in design, shorter production cycles, relatively high safety, and no risk of transmission of the complete pathogen. They are particularly promising in prevention of infectious diseases, tumor immunotherapy, and rapid response to public health threats, thanks to their capability for rapid customization, large-scale production, and comparatively easier storage, making them a key focus for global biopharma companies, governments, and research institutions.

Amid growing global public health needs, frequent emergence of infectious disease variants, rising cancer incidence, and escalating antimicrobial resistance, DNA vaccines are increasingly viewed as core next-generation vaccine and immunotherapy solutions. Governments and international agencies have significantly increased funding for research targeting emerging pathogens (such as coronaviruses, malaria, dengue etc.), thereby providing continuous policy and financial support for DNA vaccine projects. At the same time, leaps in synthetic biology, gene synthesis, plasmid design and immunogenicity optimization have shortened timelines from lab validation to clinical stages, reducing failure costs. In clinical trials, multiple DNA vaccine candidates have shown positive safety profiles and immune responses (including T cell responses), boosting the confidence of markets and investors. Moreover, demand in the animal health / veterinary vaccine sector continues to accelerate, as viral and parasitic diseases exact heavy losses in livestock/aquaculture, and DNA vaccines’ advantages in cold chain and transport make them particularly appealing, making those markets important early commercial footholds. Market valuation forecasts suggest the DNA vaccine industry will grow at a roughly 6-7% compound annual growth rate over the next decade, with market size likely to double, yielding large profit potential along the entire chain—from R&D through manufacturing and distribution.

However, for DNA vaccines to become mainstream there are substantial challenges. First is immunogenicity: the strength and durability of immune responses in humans, especially relative to protein-based or viral vector vaccines, remain uncertain; some candidates in early trials have not elicited sufficiently high neutralizing antibodies or lasting T cell responses. Second, regulatory approval processes are stringent; different jurisdictions impose very cautious requirements about safety, long-term effects, gene insertion risks, etc., which may lengthen time to market and raise costs. Third, cost and production complexity are high, particularly in plasmid production, purification, delivery systems, and storage/transport (including cold or semi-cold chain) steps. High standard GMP facilities and rigorous quality control are essential; any lapse can impact stability and safety. Fourth, market education and acceptance: medical practitioners, patients, and public health bodies are still learning; uncertainty around side effects or long-term outcomes may fuel hesitancy and reduce uptake.

Downstream, preventive applications (for infectious diseases) remain the dominant demand, especially in regions with frequent outbreaks or under-served by existing vaccine supply. Post-COVID-19, prime-boost regimens, booster shots, and heterologous immunization strategies are giving DNA vaccines renewed interest as stable, rapidly producible complements. Therapeutic applications are growing fast: cancer vaccines, chronic viral infections (e.g. HIV, HBV/HCV), parasitic/fungal disease vaccines are under clinical or early stage research. In the veterinary sector, demand is robust in poultry, aquaculture, and livestock for DNA vaccines that reduce disease losses, antibiotic use, and enhance yield. Public health bodies and government purchasers increasingly focus on total life-cycle cost: transportation & storage infrastructure, dose volume, durability, breadth of immune coverage—all of which amplify the attractiveness of DNA vaccines that are stable, require fewer doses, and have broad immune responses.

This report delivers a comprehensive overview of the global DNA Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding DNA Vaccines. The DNA Vaccines market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global DNA Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist DNA Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of DNA Vaccines Market Report

Report Metric	Details
Report Name	DNA Vaccines Market
Accounted market size in 2025	US$ 5751 million
Forecasted market size in 2032	US$ 9597 million
CAGR	7.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Recombinant Protein Vaccine Gene-Based Vaccine
Segment by Application	Human Animal
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for DNA Vaccines companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is DNA Vaccines Market growing?

Ans: The DNA Vaccines Market witnessing a CAGR of 7.7% during the forecast period 2026-2032.

What is the DNA Vaccines Market size in 2032?

Ans: The DNA Vaccines Market size in 2032 will be US$ 9597 million.

Who are the main players in the DNA Vaccines Market report?

Ans: The main players in the DNA Vaccines Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences

What are the Application segmentation covered in the DNA Vaccines Market report?

Ans: The Applications covered in the DNA Vaccines Market report are Human, Animal

What are the Type segmentation covered in the DNA Vaccines Market report?

Ans: The Types covered in the DNA Vaccines Market report are Recombinant Protein Vaccine, Gene-Based Vaccine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global DNA Vaccines Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Recombinant Protein Vaccine

1.2.3 Gene-Based Vaccine

1.3 Market by Application

1.3.1 Global DNA Vaccines Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Human

1.3.3 Animal

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global DNA Vaccines Market Perspective (2021–2032)

2.2 Global DNA Vaccines Growth Trends by Region

2.2.1 Global DNA Vaccines Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 DNA Vaccines Historic Market Size by Region (2021–2026)

2.2.3 DNA Vaccines Forecasted Market Size by Region (2027–2032)

2.3 DNA Vaccines Market Dynamics

2.3.1 DNA Vaccines Industry Trends

2.3.2 DNA Vaccines Market Drivers

2.3.3 DNA Vaccines Market Challenges

2.3.4 DNA Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top DNA Vaccines Players by Revenue

3.1.1 Global Top DNA Vaccines Players by Revenue (2021–2026)

3.1.2 Global DNA Vaccines Revenue Market Share by Players (2021–2026)

3.2 Global Top DNA Vaccines Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by DNA Vaccines Revenue

3.4 Global DNA Vaccines Market Concentration Ratio

3.4.1 Global DNA Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by DNA Vaccines Revenue in 2025

3.5 Global Key Players of DNA Vaccines Head Offices and Areas Served

3.6 Global Key Players of DNA Vaccines, Products and Applications

3.7 Global Key Players of DNA Vaccines, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 DNA Vaccines Breakdown Data by Type

4.1 Global DNA Vaccines Historic Market Size by Type (2021–2026)

4.2 Global DNA Vaccines Forecasted Market Size by Type (2027–2032)

5 DNA Vaccines Breakdown Data by Application

5.1 Global DNA Vaccines Historic Market Size by Application (2021–2026)

5.2 Global DNA Vaccines Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America DNA Vaccines Market Size (2021–2032)

6.2 North America DNA Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America DNA Vaccines Market Size by Country (2021–2026)

6.4 North America DNA Vaccines Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe DNA Vaccines Market Size (2021–2032)

7.2 Europe DNA Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe DNA Vaccines Market Size by Country (2021–2026)

7.4 Europe DNA Vaccines Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific DNA Vaccines Market Size (2021–2032)

8.2 Asia-Pacific DNA Vaccines Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific DNA Vaccines Market Size by Region (2021–2026)

8.4 Asia-Pacific DNA Vaccines Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America DNA Vaccines Market Size (2021–2032)

9.2 Latin America DNA Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America DNA Vaccines Market Size by Country (2021–2026)

9.4 Latin America DNA Vaccines Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa DNA Vaccines Market Size (2021–2032)

10.2 Middle East & Africa DNA Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa DNA Vaccines Market Size by Country (2021–2026)

10.4 Middle East & Africa DNA Vaccines Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck DNA Vaccines Introduction

11.1.4 Merck Revenue in DNA Vaccines Business (2021–2026)

11.1.5 Merck Recent Development

11.2 GSK

11.2.1 GSK Company Details

11.2.2 GSK Business Overview

11.2.3 GSK DNA Vaccines Introduction

11.2.4 GSK Revenue in DNA Vaccines Business (2021–2026)

11.2.5 GSK Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi DNA Vaccines Introduction

11.3.4 Sanofi Revenue in DNA Vaccines Business (2021–2026)

11.3.5 Sanofi Recent Development

11.4 Zoties

11.4.1 Zoties Company Details

11.4.2 Zoties Business Overview

11.4.3 Zoties DNA Vaccines Introduction

11.4.4 Zoties Revenue in DNA Vaccines Business (2021–2026)

11.4.5 Zoties Recent Development

11.5 Elanco

11.5.1 Elanco Company Details

11.5.2 Elanco Business Overview

11.5.3 Elanco DNA Vaccines Introduction

11.5.4 Elanco Revenue in DNA Vaccines Business (2021–2026)

11.5.5 Elanco Recent Development

11.6 Boehringer-Ingelheim

11.6.1 Boehringer-Ingelheim Company Details

11.6.2 Boehringer-Ingelheim Business Overview

11.6.3 Boehringer-Ingelheim DNA Vaccines Introduction

11.6.4 Boehringer-Ingelheim Revenue in DNA Vaccines Business (2021–2026)

11.6.5 Boehringer-Ingelheim Recent Development

11.7 Indian Immunologicals

11.7.1 Indian Immunologicals Company Details

11.7.2 Indian Immunologicals Business Overview

11.7.3 Indian Immunologicals DNA Vaccines Introduction

11.7.4 Indian Immunologicals Revenue in DNA Vaccines Business (2021–2026)

11.7.5 Indian Immunologicals Recent Development

11.8 Plumbline Life Sciences

11.8.1 Plumbline Life Sciences Company Details

11.8.2 Plumbline Life Sciences Business Overview

11.8.3 Plumbline Life Sciences DNA Vaccines Introduction

11.8.4 Plumbline Life Sciences Revenue in DNA Vaccines Business (2021–2026)

11.8.5 Plumbline Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

GSK

Elanco

Boehringer Ingelheim

Indian Immunologicals

Plumbline Life Sciences

Sanofi

Zoties

List of Tables

Table 1. Global DNA Vaccines Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Recombinant Protein Vaccine

Table 3. Key Players of Gene-Based Vaccine

Table 4. Global DNA Vaccines Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global DNA Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global DNA Vaccines Market Size by Region (US$ Million), 2021–2026

Table 7. Global DNA Vaccines Market Share by Region (2021–2026)

Table 8. Global DNA Vaccines Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global DNA Vaccines Market Share by Region (2027–2032)

Table 10. DNA Vaccines Market Trends

Table 11. DNA Vaccines Market Drivers

Table 12. DNA Vaccines Market Challenges

Table 13. DNA Vaccines Market Restraints

Table 14. Global DNA Vaccines Revenue by Players (US$ Million), 2021–2026

Table 15. Global DNA Vaccines Market Share by Players (2021–2026)

Table 16. Global Top DNA Vaccines Players by Tier (Tier 1, Tier 2, and Tier 3), based on DNA Vaccines Revenue, 2025

Table 17. Ranking of Global Top DNA Vaccines Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by DNA Vaccines Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of DNA Vaccines, Headquarters and Area Served

Table 20. Global Key Players of DNA Vaccines, Products and Applications

Table 21. Global Key Players of DNA Vaccines, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global DNA Vaccines Market Size by Type (US$ Million), 2021–2026

Table 24. Global DNA Vaccines Revenue Market Share by Type (2021–2026)

Table 25. Global DNA Vaccines Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global DNA Vaccines Revenue Market Share by Type (2027–2032)

Table 27. Global DNA Vaccines Market Size by Application (US$ Million), 2021–2026

Table 28. Global DNA Vaccines Revenue Market Share by Application (2021–2026)

Table 29. Global DNA Vaccines Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global DNA Vaccines Revenue Market Share by Application (2027–2032)

Table 31. North America DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America DNA Vaccines Market Size by Country (US$ Million), 2021–2026

Table 33. North America DNA Vaccines Market Size by Country (US$ Million), 2027–2032

Table 34. Europe DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe DNA Vaccines Market Size by Country (US$ Million), 2021–2026

Table 36. Europe DNA Vaccines Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific DNA Vaccines Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific DNA Vaccines Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific DNA Vaccines Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America DNA Vaccines Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America DNA Vaccines Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa DNA Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa DNA Vaccines Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa DNA Vaccines Market Size by Country (US$ Million), 2027–2032

Table 46. Merck Company Details

Table 47. Merck Business Overview

Table 48. Merck DNA Vaccines Product

Table 49. Merck Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 50. Merck Recent Development

Table 51. GSK Company Details

Table 52. GSK Business Overview

Table 53. GSK DNA Vaccines Product

Table 54. GSK Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 55. GSK Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi DNA Vaccines Product

Table 59. Sanofi Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 60. Sanofi Recent Development

Table 61. Zoties Company Details

Table 62. Zoties Business Overview

Table 63. Zoties DNA Vaccines Product

Table 64. Zoties Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 65. Zoties Recent Development

Table 66. Elanco Company Details

Table 67. Elanco Business Overview

Table 68. Elanco DNA Vaccines Product

Table 69. Elanco Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 70. Elanco Recent Development

Table 71. Boehringer-Ingelheim Company Details

Table 72. Boehringer-Ingelheim Business Overview

Table 73. Boehringer-Ingelheim DNA Vaccines Product

Table 74. Boehringer-Ingelheim Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 75. Boehringer-Ingelheim Recent Development

Table 76. Indian Immunologicals Company Details

Table 77. Indian Immunologicals Business Overview

Table 78. Indian Immunologicals DNA Vaccines Product

Table 79. Indian Immunologicals Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 80. Indian Immunologicals Recent Development

Table 81. Plumbline Life Sciences Company Details

Table 82. Plumbline Life Sciences Business Overview

Table 83. Plumbline Life Sciences DNA Vaccines Product

Table 84. Plumbline Life Sciences Revenue in DNA Vaccines Business (US$ Million), 2021–2026

Table 85. Plumbline Life Sciences Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. DNA Vaccines Picture

Figure 2. Global DNA Vaccines Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global DNA Vaccines Market Share by Type: 2025 vs 2032

Figure 4. Recombinant Protein Vaccine Features

Figure 5. Gene-Based Vaccine Features

Figure 6. Global DNA Vaccines Market Size by Application (US$ Million), 2021–2032

Figure 7. Global DNA Vaccines Market Share by Application: 2025 vs 2032

Figure 8. Human Case Studies

Figure 9. Animal Case Studies

Figure 10. DNA Vaccines Report Years Considered

Figure 11. Global DNA Vaccines Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global DNA Vaccines Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global DNA Vaccines Market Share by Region: 2025 vs 2032

Figure 14. Global DNA Vaccines Market Share by Players in 2025

Figure 15. Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by DNA Vaccines Revenue in 2025

Figure 17. North America DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America DNA Vaccines Market Share by Country (2021–2032)

Figure 19. United States DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe DNA Vaccines Market Share by Country (2021–2032)

Figure 23. Germany DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific DNA Vaccines Market Share by Region (2021–2032)

Figure 31. China DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America DNA Vaccines Market Share by Country (2021–2032)

Figure 39. Mexico DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa DNA Vaccines Market Share by Country (2021–2032)

Figure 43. Israel DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE DNA Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Merck Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 47. GSK Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 48. Sanofi Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 49. Zoties Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 50. Elanco Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 51. Boehringer-Ingelheim Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 52. Indian Immunologicals Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 53. Plumbline Life Sciences Revenue Growth Rate in DNA Vaccines Business (2021–2026)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global DNA Vaccination Market Research Report 2024

Global Nucleic Vaccine Market Insights Forecast to 2030

Global Human DNA Vaccines Market Insights Forecast to 2030

Global Pet DNA Vaccines Market Research Report 2025

Global Genetic Vaccine Market Insights Forecast to 2030

Global Nucleic Acid Vaccine Market Insights Forecast to 2030

Global Recombinant Protein Vaccine Market Insights Forecast to 2030

Global Recombinant Vector Vaccines Market Insights Forecast to 2030

Global RNA Vaccines Market Insights Forecast to 2030

Global Plasmid DNA Manufacturing Market Insights Forecast to 2030

Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Global Animal Vaccines Market Insights Forecast to 2030

Global Pet Recombinant Vaccine Market Research Report 2025

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

Global Recombinant Influenza Vaccine Market Research Report 2024

Global DNA and Gene Chips Market Insights Forecast to 2030

Global Biopharmaceutical and Vaccine Production Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions